Standard indication of immunotherapy for the treatment of cancer
Pharmacol Res
.
1992 Sep:26 Suppl 2:100-1.
doi: 10.1016/1043-6618(92)90617-k.
Authors
E Bolli
1
,
L Tixi
,
A Mori
,
A Guglielmi
,
C Aschele
,
E Rovini
,
A Sobrero
Affiliation
1
Istituto Nazionale per la Ricerca sul Cancro, Genova.
PMID:
1384019
DOI:
10.1016/1043-6618(92)90617-k
No abstract available
MeSH terms
Humans
Immunotherapy*
Interferons / therapeutic use
Levamisole / therapeutic use
Neoplasms / therapy*
Substances
Levamisole
Interferons